Evidence map›Paper›PMID 32541906›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Stimulation of muscarinic acetylcholine M

Amy C Leach, Mark J Ferris

Abstract readComment
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Amy C LeachDepartment of Physiology and Pharmacology, Program in Neuroscience, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.ORCID http://orcid.org/0000-0003-3683-8633
Mark J FerrisDepartment of Physiology and Pharmacology, Program in Neuroscience, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA. mferris@wakehealth.edu.ORCID http://orcid.org/0000-0002-0127-7955

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOWLETT, ALLYN C · 1991 to 2019
$30.8M
Wake Forest Translational Alcohol Research Center (WF-TARC)P50AA026117 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jeffrey L. Weiner · 2018 to 2026
$16.2M
The Neurobiology of Drug AbuseT32DA041349 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SARA RAULERSON JONES · 2017 to 2026
$1.8M
nAChR sensitivity and individual differences in drug abuse vulnerabilityR00DA031791 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2015 to 2017
$743k
NIAAA NIH HHS P50 AA026117NIDA NIH HHS P50 DA006634NIDA NIH HHS T32 DA041349
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CocaineReceptor, Muscarinic M1AcetylcholineAnimalsCholinergic AgentsRatsReceptor, Muscarinic M4AcetylcholineCholinergic AgentsCocaineReceptor, Muscarinic M1Receptor, Muscarinic M4

Identifiers

PMID32541906
PMCPMC7547686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.